戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 n in human beta-cardiac myosin II results in familial hypertrophic cardiomyopathy).
2 ing protein C), are the most common cause of familial hypertrophic cardiomyopathy.
3 physical mechanism of a mutation that causes familial hypertrophic cardiomyopathy.
4 C were determined in unrelated patients with familial hypertrophic cardiomyopathy.
5 unt for approximately 15 percent of cases of familial hypertrophic cardiomyopathy.
6 lic dysfunction resembling the human form of familial hypertrophic cardiomyopathy.
7 nse mutations in alpha-tropomyosin can cause familial hypertrophic cardiomyopathy.
8 n gene have been shown to be responsible for familial hypertrophic cardiomyopathy.
9 property that may be a general phenomenon in familial hypertrophic cardiomyopathy.
10 al proportion (30-40%) of genotyped cases of familial hypertrophic cardiomyopathy.
11 ons in the cardiac gene are a major cause of familial hypertrophic cardiomyopathy.
12  cause both dilated cardiomyopathy (DCM) and familial hypertrophic cardiomyopathy.
13 mutations in human alpha-cardiac actin cause familial hypertrophic cardiomyopathy.
14 ardiac troponin I (cTnI) mutations can cause familial hypertrophic cardiomyopathy.
15  in cTnT have been linked to severe forms of familial hypertrophic cardiomyopathy.
16 ith an R146G mutation [cTnI(146G)] linked to familial hypertrophic cardiomyopathy.
17  associated with a clinically severe form of familial hypertrophic cardiomyopathy.
18 A63V and K70T, each previously implicated in familial hypertrophic cardiomyopathy.
19  mutant myosins found in disease states like familial hypertrophic cardiomyopathy.
20  the cardiac MyBP-C gene are associated with familial hypertrophic cardiomyopathy.
21 in-II mutation responsible for some forms of familial hypertrophic cardiomyopathy.
22  troponin I (cTnI) have been associated with familial hypertrophic cardiomyopathy.
23 diac motor protein genes are associated with familial hypertrophic cardiomyopathy.
24 gotes may account for focal myocyte death in familial hypertrophic cardiomyopathy.
25 utations within the gene have been linked to familial hypertrophic cardiomyopathy.
26 xhibit the histopathologic features of human familial hypertrophic cardiomyopathy.
27  domain of the myosin heavy chain that cause familial hypertrophic cardiomyopathy.
28 f the beta-cardiac myosin heavy chain causes familial hypertrophic cardiomyopathy.
29  encoding human cardiac troponin T can cause familial hypertrophic cardiomyopathy, a disease that is
30 nin T (TnT) I79N mutation has been linked to familial hypertrophic cardiomyopathy and a high incidenc
31 ofilament Ca sensitivity are associated with familial hypertrophic cardiomyopathy and confer a high r
32 nin T (TnT) I79N mutation has been linked to familial hypertrophic cardiomyopathy and high incidence
33  thick filament proteins are associated with familial hypertrophic cardiomyopathy and other heart and
34 strated by the implications to be drawn from familial hypertrophic cardiomyopathy and the 50 new gene
35 d patients with hereditary long QT syndrome, familial hypertrophic cardiomyopathy, and familial dilat
36     Fifteen percent of the mutations causing familial hypertrophic cardiomyopathy are in the troponin
37 d lines develop a pathology similar to human familial hypertrophic cardiomyopathy but within a dramat
38                                              Familial hypertrophic cardiomyopathy can be caused by mu
39 We also propose that mice bearing homozygous familial hypertrophic cardiomyopathy-causing mutations m
40 f all of the known cTnT mutations that cause familial hypertrophic cardiomyopathy fall within the TNT
41     To test this hypothesis, we utilized the familial hypertrophic cardiomyopathy (FHC) alpha-Tm E180
42        Troponin T (TnT) mutations that cause familial hypertrophic cardiomyopathy (FHC) and sudden ca
43  hemodynamic abnormalities characteristic of familial hypertrophic cardiomyopathy (FHC) and sudden de
44 studied the clinical and genetic features of familial hypertrophic cardiomyopathy (FHC) caused by an
45                                              Familial hypertrophic cardiomyopathy (FHC) has been link
46       Secondly two point mutations linked to familial hypertrophic cardiomyopathy (FHC) have been ide
47                    The heterogenic nature of familial hypertrophic cardiomyopathy (FHC) in humans sug
48 T) F110I and R278C mutations associated with familial hypertrophic cardiomyopathy (FHC) in humans.
49 runc) in the cardiac troponin T (cTnT) model familial hypertrophic cardiomyopathy (FHC) in humans.
50 , Arg403Gln (R403Q), causes a severe form of familial hypertrophic cardiomyopathy (FHC) in humans.
51                                              Familial hypertrophic cardiomyopathy (FHC) is a genetic
52                                              Familial hypertrophic cardiomyopathy (FHC) is a heritabl
53                                              Familial hypertrophic cardiomyopathy (FHC) is a human ge
54                                              Familial hypertrophic cardiomyopathy (FHC) is a major ca
55                                              Familial hypertrophic cardiomyopathy (FHC) is an autosom
56                                              Familial hypertrophic cardiomyopathy (FHC) is an inherit
57                                              Familial hypertrophic cardiomyopathy (FHC) is an inherit
58                                              Familial hypertrophic cardiomyopathy (FHC) is caused by
59                                              Familial hypertrophic cardiomyopathy (FHC) is caused by
60                                              Familial hypertrophic cardiomyopathy (FHC) is one of the
61 fect of troponin (Tn) T mutations that cause familial hypertrophic cardiomyopathy (FHC) on cardiac mu
62 light chain (RLC) shown to cause a malignant familial hypertrophic cardiomyopathy (FHC) phenotype wer
63 on-contraction coupling in cardiac muscle of familial hypertrophic cardiomyopathy (FHC) remains poorl
64                             A mouse model of familial hypertrophic cardiomyopathy (FHC) was generated
65 sin regulatory light chain (RLC) gene causes familial hypertrophic cardiomyopathy (FHC) with a phenot
66 ative sarcomere protein gene mutations cause familial hypertrophic cardiomyopathy (FHC), a disease ch
67 (MHC) was the first mutation to be linked to familial hypertrophic cardiomyopathy (FHC), a primary di
68 light chain (RLC) lead to the development of familial hypertrophic cardiomyopathy (FHC), an autosomal
69 e of the sarcomeric proteins associated with familial hypertrophic cardiomyopathy (FHC), an autosomal
70 e dilated cardiomyopathy(DCM) independent of familial hypertrophic cardiomyopathy (FHC), and TnT-K273
71  chain gene (MYH7) have been associated with familial hypertrophic cardiomyopathy (FHC), but no study
72 ion as well as the molecular pathogenesis of familial hypertrophic cardiomyopathy (FHC), eight FHC-li
73 hough sarcomere protein gene mutations cause familial hypertrophic cardiomyopathy (FHC), individuals
74  a tropomyosin (TM) mutation associated with familial hypertrophic cardiomyopathy (FHC), we generated
75 TnT) cause a dominant genetic heart disease, familial hypertrophic cardiomyopathy (FHC).
76          These mutations are associated with familial hypertrophic cardiomyopathy (FHC).
77  single-site mutations D175N and E180G cause familial hypertrophic cardiomyopathy (FHC).
78 ) mutation in the cardiac ELC known to cause familial hypertrophic cardiomyopathy (FHC).
79 ory light chain (RLC) is sufficient to cause familial hypertrophic cardiomyopathy (FHC).
80 ain (RLC) can cause a malignant phenotype of familial hypertrophic cardiomyopathy (FHC).
81 s of expressing the mutant MHC implicated in familial hypertrophic cardiomyopathy (FHC).
82 is replaced with asparagine) associated with familial hypertrophic cardiomyopathy (FHC).
83 ment protein troponin T (TnT) are a cause of familial hypertrophic cardiomyopathy (FHC).
84 tions in cardiac troponin T (cTnT) can cause familial hypertrophic cardiomyopathy (FHC).
85        A naturally occurring animal model of familial hypertrophic cardiomyopathy (FHCM) is lacking.
86  hypertrophy (LVH), the clinical hallmark of familial hypertrophic cardiomyopathy (FHCM), is absent i
87                                              Familial hypertrophic cardiomyopathy has been associated
88                                              Familial hypertrophic cardiomyopathy (HCM) can be caused
89                                              Familial hypertrophic cardiomyopathy (HCM) has been wide
90 stand the clinical and molecular features of familial hypertrophic cardiomyopathy (HCM) in which a mi
91                                              Familial hypertrophic cardiomyopathy (HCM) is a prevalen
92                                              Familial hypertrophic cardiomyopathy (HCM) is a primary
93                                              Familial hypertrophic cardiomyopathy (HCM) is caused by
94                                              Familial hypertrophic cardiomyopathy (HCM) is caused by
95                                              Familial hypertrophic cardiomyopathy (HCM) is the most c
96 he discovery of the first mutation linked to familial hypertrophic cardiomyopathy (HCM), an astonishi
97 T) account for approximately 15% of cases of familial hypertrophic cardiomyopathy (HCM).
98 se results suggest that the primary cause of familial hypertrophic cardiomyopathy, in some cases, is
99                                              Familial hypertrophic cardiomyopathy is a clinically and
100                                              Familial hypertrophic cardiomyopathy is a disease caused
101                                        Human familial hypertrophic cardiomyopathy is the most common
102 iac myosin binding protein-C or titin, cause familial hypertrophic cardiomyopathies, it is important
103 ac failure, Galphaq overexpression and human familial hypertrophic cardiomyopathy mutant myosin bindi
104          This finding supports evidence that familial hypertrophic cardiomyopathy mutations occurring
105                            The effect of the familial hypertrophic cardiomyopathy mutations, A13T, F1
106 , and alpha-tropomyosin account for > 45% of familial hypertrophic cardiomyopathy, none were found he
107 alpha-cardiac myosin isoform display typical familial hypertrophic cardiomyopathy pathology.
108                                 However, the familial hypertrophic cardiomyopathy-related mutation of
109 ta14 mutation of troponin T, associated with familial hypertrophic cardiomyopathy, results in an incr
110 del, p.Delta160E) in TNNT2 in a patient with familial hypertrophic cardiomyopathy showing progressive
111 in T are responsible for 15% of all cases of familial hypertrophic cardiomyopathy, the leading cause
112 n (Tn)T and alpha-tropomyosin were linked to familial hypertrophic cardiomyopathy, thus transforming
113    To understand further the pathogenesis of familial hypertrophic cardiomyopathy, we determined how

 
Page Top